The Influence of Aerobic Exercise on Serum Brain Natriuretic Peptide and C- Reactive Protein in Cardiovascular Disease
AEBNPCRP
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The purpose of this study was to investigate the effects of 8 weeks of aerobic exercise on serum concentrations of Brain Natriuretic Peptide and C - reactive protein in patients with cardiovascular disease. Patients were divided randomly into two groups: control and experimental aerobic group. This study was done with two - stage blood sampling: at the beginning and at the end of the treatment phase. All subjects were requested to avoid any exercise at least 48 hours before blood sampling. To study Brain Natriuretic Peptide and C - reactive protein changes, 5 milliliters of blood were taken from patient's brachial vein. Blood samples for subsequent measurements were frozen immediately and transported to the Hormone Laboratory for serum separation. The experimental group did the aerobic exercise programs for 8 weeks for 3 sessions per week and the control group did not receive any training. After completion of training, the final blood samplings were performed. Exercise intensity according to the heart rate remained stable until the last week. Brain Natriuretic Peptide and C - reactive protein levels were measured by ELISA tests. All statistical analysis were done using SPSS software (version 16) and at the significance level of p≤ 0.05
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 13, 2015
CompletedFirst Posted
Study publicly available on registry
June 24, 2015
CompletedMay 10, 2016
May 1, 2016
2 months
June 13, 2015
May 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brain Natriuretic Peptide
8 weeks
serum C - reactive protein
8 weeks
Secondary Outcomes (3)
serum lipoproteins
8 weeks
Body Mass Index
8 weeks
blood pressure
8 weeks
Study Arms (2)
intervention
EXPERIMENTALAerobic exercise+ blood sampling
control
NO INTERVENTIONBlood sampling
Interventions
Eligibility Criteria
You may qualify if:
- In this trial patients with coronary artery disease more than 70 percent at least in one coronary vessel with Ejection Fraction more than 40 percent in recent Echo cardiograph without acute evidence of ischemia or congestive heart failure symptoms were selected and are divide randomly into two groups.
You may not qualify if:
- Patients with acute evidence of ischemia or congestive heart failure symptoms are excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dr Mohammad Ali Ostovan, Cardiologist
Shiraz University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master
Study Record Dates
First Submitted
June 13, 2015
First Posted
June 24, 2015
Study Start
March 1, 2015
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
May 10, 2016
Record last verified: 2016-05